29.07.2011 • News

Eastman Chemical Q2 Profit Up

Eastman reported net income for the second quarter of $211 million or $2.91 per share, compared to $148 million or $2.02 per share for the year-ago quarter.

Income from continuing operations for the second quarter was $210 million or $2.90 per share, compared to $141 million or $1.92 per share in the prior year quarter.

Excluding items, adjusted earnings per share from continuing operations were $2.76, compared to $1.95 in the prior year quarter.

Sales for the second quarter rose to $1.89 billion from $1.50 billion a year earlier.

Analysts polled by Thomson Reuters expected the company to earn $2.62 per share on revenue of $1.81 billion for the second quarter. Analysts' estimates typically exclude special items.

Looking forward, the company said it expects third quarter earnings per share to be slightly higher than third quarter 2010 earnings per share of $2.22.

The company also said it expect full year 2011 earnings per share to be slightly higher than $9.25. In April, Eastman had forecast full year 2011 earnings per share to be slightly higher than $9.

Analysts currently expect the company to earn $2.35 per share for the third quarter and $9.31 per share for the full year 2011.

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read